SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GelTex Pharmaceuticals (GELX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NY0001 who wrote (40)10/28/1997 1:05:00 AM
From: James Silverman  Read Replies (1) of 127
 
Neuro,
Can you post some info on the neutraceuticals? In particular what effects on the various lipids will they have and under what sort of dosing regime? For example, what impacts do they have on the following lipid categories: LDL, HDL, Triglycerides, LP(a) and Total cholesterol? Do users have to ingest the food daily to get an impacting benefit?
Answering these questions and comparing them to Statins and other cholesterol altering drugs as well as what sort of reductions in cholesterol or increases in HDL Doctors are looking for may help determine whether these will be competing technologies or merely complimentary. For reference, Statins can lower LDL cholesterol by up to and over 30%. Kosp's Niaspan increases HDL by about 30%. GELX cholestagel in combination with low dose Statin reduced LDL by over 30% as well, I believe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News